In Silico Exploration of CD200 as a Therapeutic Target for COVID-19

ABSTRACT:

SUBMITTER: Perovic V 

PROVIDER: S-EPMC11205781 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature